cbdMD Announces Additional Conversions of Its Convertible Notes
Charlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly ...
Vanda's Letter to FDA Commissioner Highlights Faulty Gastroparesis NDA Review
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review.
Carlsquare Expands North American Presence with Boston Office and Appointment of Greg Hartlein as Managing Director
Carlsquare, a global technology investment bank, announced the opening of its Boston office, marking its third North American location after San Francisco (April 2023) and Vancouver (August 2023).
King Faisal Prize Laureates in Medicine & Science Receive $400,000 For their Breakthrough Discoveries in Cellular Engineering and Nanotechnology
Professor Michel Sadelain, of Canadian origins, was announced the 2025 laureate for King Faisal Prize in Medicine for his groundbreaking contributions to Chimeric Antigen Receptor (CAR) T-cell therapy ...
NFWF Announces $14.7 Million in Grants to Bolster Regenerative Agriculture on Working Lands
Since 2011, the Conservation Partners Program has awarded 322 grants worth more than $85 million and leveraged an additional $107 million in matching contributions, generating a total conservation ...
NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
Revenues in 4Q24 increased approximately 50% versus 4Q23Cash balance as of 12/31/24 was approximately $3.7 millionCARMEL, Ind., Jan. 08, 2025 ...
Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
The formation of Gain’s new Clinical Advisory Board marks a significant strategic step forward for Gain, as GT-02287 advances into Parkinson’s disease patients,” stated Gene Mack, CEO of Gain ...
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025
The poster is titled Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tutors ...
NOLA.com10h
See the Super Bowl LIX logo designed by a local artist: 'Love letter to New Orleans'
Super Bowl LIX made an excellent choice when selecting Black masking Indian 'Queen’ Tahj to compose the logo for the big game ...
MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab
New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis ...
EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today ...
Scientific American11h
American Global Health Leadership in a Second Trump Administration
The Trump administration may undermine U.S. leadership and the international system of global health cooperation. Pandemic preparedness, resilient health systems and reproductive rights will suffer wo ...